Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124590904 | 12459090 | 4 | F | 20130409 | 20160823 | 20160613 | 20160829 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201606001632 | ELI LILLY AND CO | 27.06 | YR | M | Y | 62.00000 | KG | 20160829 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124590904 | 12459090 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, QD | Y | 21427 | 20 | MG | CAPSULE | QD | |||||
| 124590904 | 12459090 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 100 MG, QD | Y | 21427 | 100 | MG | CAPSULE | QD | |||||
| 124590904 | 12459090 | 3 | SS | LULLAN | PEROSPIRONE HYDROCHLORIDE | 1 | Oral | 200 MG, QD | Y | 0 | 200 | MG | TABLET | QD | |||||
| 124590904 | 12459090 | 4 | SS | LUVOX | FLUVOXAMINE MALEATE | 1 | Oral | 2250 MG, QD | Y | 0 | 2250 | MG | TABLET | QD | |||||
| 124590904 | 12459090 | 5 | SS | DEPAKENE | VALPROIC ACID | 1 | Oral | 3600 MG, QD | Y | 0 | 3600 | MG | TABLET | QD | |||||
| 124590904 | 12459090 | 6 | SS | HIRNAMIN /00038601/ | LEVOMEPROMAZINE | 1 | Oral | 25 MG, QD | Y | 0 | 25 | MG | TABLET | QD | |||||
| 124590904 | 12459090 | 7 | SS | HIRNAMIN /00038601/ | LEVOMEPROMAZINE | 1 | Oral | 350 MG, QD | Y | 0 | 350 | MG | TABLET | QD | |||||
| 124590904 | 12459090 | 8 | SS | ROHYPNOL | FLUNITRAZEPAM | 1 | Oral | 13 MG, QD | Y | 0 | 13 | MG | TABLET | QD | |||||
| 124590904 | 12459090 | 9 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 13 MG, QD | Y | 0 | 13 | MG | ORAL LIQUID | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124590904 | 12459090 | 1 | Bipolar disorder |
| 124590904 | 12459090 | 2 | Suicide attempt |
| 124590904 | 12459090 | 3 | Suicide attempt |
| 124590904 | 12459090 | 4 | Suicide attempt |
| 124590904 | 12459090 | 5 | Suicide attempt |
| 124590904 | 12459090 | 6 | Bipolar disorder |
| 124590904 | 12459090 | 7 | Suicide attempt |
| 124590904 | 12459090 | 8 | Suicide attempt |
| 124590904 | 12459090 | 9 | Suicide attempt |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124590904 | 12459090 | LT |
| 124590904 | 12459090 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124590904 | 12459090 | Coma | |
| 124590904 | 12459090 | Coma blister | |
| 124590904 | 12459090 | Dehydration | |
| 124590904 | 12459090 | Intentional product misuse | |
| 124590904 | 12459090 | Neuroleptic malignant syndrome | |
| 124590904 | 12459090 | Off label use | |
| 124590904 | 12459090 | Pleural effusion | |
| 124590904 | 12459090 | Pneumonia | |
| 124590904 | 12459090 | Rhabdomyolysis | |
| 124590904 | 12459090 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124590904 | 12459090 | 1 | 20130409 | 20131007 | 0 | |
| 124590904 | 12459090 | 2 | 20131008 | 20131008 | 0 | |
| 124590904 | 12459090 | 3 | 20131008 | 20131008 | 0 | |
| 124590904 | 12459090 | 4 | 20131008 | 20131008 | 0 | |
| 124590904 | 12459090 | 5 | 20131008 | 20131008 | 0 | |
| 124590904 | 12459090 | 6 | 20130822 | 20131007 | 0 | |
| 124590904 | 12459090 | 7 | 20131008 | 20131008 | 0 | |
| 124590904 | 12459090 | 8 | 20131008 | 20131008 | 0 | |
| 124590904 | 12459090 | 9 | 20131008 | 20131008 | 0 |